Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/23050
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2021-12-07T12:27:54Z | - |
dc.date.available | 2021-12-07T12:27:54Z | - |
dc.date.issued | 2008-05 | - |
dc.identifier.citation | Çelebi, S. vd. (2008). ''Nosocomial candidaemia in children: Results of a 9-year study''. Mycoses, 51(3), 248 - 257. | en_US |
dc.identifier.issn | 1439-0507 | - |
dc.identifier.uri | https://doi.org/10.1111/j.1439-0507.2007.01464.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1439-0507.2007.01464.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/23050 | - |
dc.description.abstract | The aim of this study was to determine changes in the incidence of nosocomial candidaemia and to evaluate the risk factors, demographic features, treatment and clinical outcome associated with candidaemia in a Turkish tertiary care paediatric unit within a 9-year period. The data of children who were diagnosed as nosocomial candidaemia, were examined in this study. Between January 1997 and December 2005, a total of 102 nosocomial candidaemia episodes were identified in 102 patients. The rate of nosocomial candidaemia in our clinic increased from 3.2 cases per 1000 admissions in 1997-1999, to 5.5 per 1000 admissions in 2000-2002 and to 6.9 per 1000 admissions in 2003-2005 (P = 0.003). The species most frequently causing candidaemia were Candida albicans (39.2%), Candida parapsilosis (21.6%) and Candida tropicalis (15.7%). The mortality of C. albicans (37.5%), was significantly higher than the mortality of non-albicans species (17.7%) (P = 0.04). Independent risk factors associated with candidaemia-related deaths by logistic regression analysis were disseminated candidiasis (odds ratio, 5.7; P = 0.01), paediatric intensive care unit stay (odds ratio, 8.1; P = 0.001), prolonged antibiotics therapy (odds ratio, 5.2; P = 0.014), use of total parenteral nutrition (odds ratio, 4.4; P = 0.038) and mechanical ventilation (odds ratio, 4.9; P = 0.01). The rate of nosocomial candidaemia in our c | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Children | en_US |
dc.subject | Nosocomial candidaemia | en_US |
dc.subject | Risk factors for candidaemia | en_US |
dc.subject | Candida albicans | en_US |
dc.subject | Candida parapsilosis | en_US |
dc.subject | Candida tropicalis | en_US |
dc.subject | Risk-factors | en_US |
dc.subject | Fungal-infections | en_US |
dc.subject | Clinical-features | en_US |
dc.subject | Candidemia | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Albicans | en_US |
dc.subject | trends | en_US |
dc.subject | Fluconazole | en_US |
dc.subject | Candidiasis | en_US |
dc.subject | Fungemia | en_US |
dc.subject | Mycology | en_US |
dc.subject | Dermatology | en_US |
dc.subject.mesh | Antifungal agents | en_US |
dc.subject.mesh | Candida | en_US |
dc.subject.mesh | Candidiasis | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Cross infection | en_US |
dc.subject.mesh | Fungemia | en_US |
dc.subject.mesh | Hospitals | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant, newborn | en_US |
dc.subject.mesh | Intensive care units, neonatal | en_US |
dc.subject.mesh | Parenteral nutrition | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.title | Nosocomial candidaemia in children: Results of a 9-year study | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000254791800008 | tr_TR |
dc.identifier.scopus | 2-s2.0-41849143805 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyoistatistik Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0003-0297-846X | tr_TR |
dc.identifier.startpage | 248 | tr_TR |
dc.identifier.endpage | 257 | tr_TR |
dc.identifier.volume | 51 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Mycoses | en_US |
dc.contributor.buuauthor | Çelebi, Solmaz | - |
dc.contributor.buuauthor | Hacımustafaoğlu, Mustafa Kemal | - |
dc.contributor.buuauthor | Özdemir, Özlem | - |
dc.contributor.buuauthor | Özkaya, Güven | - |
dc.contributor.researcherid | A-4421-2016 | tr_TR |
dc.identifier.pubmed | 18399906 | tr_TR |
dc.subject.wos | Dermatology | en_US |
dc.subject.wos | Mycology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 7006095295 | tr_TR |
dc.contributor.scopusid | 6602154166 | tr_TR |
dc.contributor.scopusid | 26647804400 | tr_TR |
dc.contributor.scopusid | 16316866500 | tr_TR |
dc.subject.scopus | Candidemia; Invasive Candidiasis; Candida Parapsilosis | en_US |
dc.subject.emtree | Amikacin | en_US |
dc.subject.emtree | Amphotericin b deoxycholate | en_US |
dc.subject.emtree | Amphotericin b lipid complex | en_US |
dc.subject.emtree | Antibiotic agent | en_US |
dc.subject.emtree | Carbapenem | en_US |
dc.subject.emtree | Cefotaxime | en_US |
dc.subject.emtree | Fluconazole | en_US |
dc.subject.emtree | flucytosine | en_US |
dc.subject.emtree | Steroid | en_US |
dc.subject.emtree | Vancomycin | en_US |
dc.subject.emtree | Absence of side effects | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Antibiotic therapy | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Artificial ventilation | en_US |
dc.subject.emtree | Candida albicans | en_US |
dc.subject.emtree | Candida parapsilosis | en_US |
dc.subject.emtree | Candida tropicalis | en_US |
dc.subject.emtree | Candidemia | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Childhood disease | en_US |
dc.subject.emtree | Demography | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Hospital admission | en_US |
dc.subject.emtree | Hospital infection | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hypokalemia | en_US |
dc.subject.emtree | Incidence | en_US |
dc.subject.emtree | Infant | en_US |
dc.subject.emtree | Intensive care unit | en_US |
dc.subject.emtree | Logistic regression analysis | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Monotherapy | en_US |
dc.subject.emtree | Mortality | en_US |
dc.subject.emtree | Newborn | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Total parenteral nutrition | en_US |
dc.subject.emtree | Treatment duration | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.